Search Results for "Recent Markers In Polycystic Ovarian Syndrome"
Original Source: Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance.
The aim of this study was to evaluate ischemia-modified albumin levels (IMA) in polycystic ovary syndrome (PCOS) cases with and without insulin resistance and the correlation of IMA with carotid intima media thickness, homocysteine, and high-sensitivity C-reactive protein levels. Significantly higher levels of IMA in young lean PCOS cases, more relevant in insulin resistant cases, indicates chronic hypoxia and oxidative stress which might play a role in the metabolic consequences in PCOS.
Matching Channels
Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. These substances can be found in the blood, in t...
Autosomal Dominant Polycystic Kidney Disease ADPKD
Ovarian cancer is cancer that starts in the female reproductive organs, the ovaries. It is the fifth most common cancer among women. Women at risk of Ovarian cancer are those who have had fe...
Matching News
Study provides new insights about polycystic ovarian syndrome, insulin resistance
A group of tiny RNA molecules with a big role in regulating gene expression also appear to have a role in causing insulin resistance in woman with polycystic ovary syndrome and, perhaps, in all women,...
Progestin treatment for polycystic ovarian syndrome may reduce pregnancy chances
The hormone progestin, often given as a first step in infertility treatment for polycystic ovary syndrome (PCOS), appears to decrease the odds of conception and of giving birth, according to a study b...
Polycystic ovarian syndrome ups risk of type 2 diabetes
(HealthDay) -- Middle-aged women with polycystic ovary syndrome (PCOS) are at increased risk of developing type 2 diabetes, according to a prospective long-term study published online June 14 in Diabe...
NIH panel recommends name change for polycystic ovary syndrome
An independent panel convened by the National Institutes of Health has concluded that the name of a common hormone disorder in women, polycystic ovary syndrome (PCOS), causes confusion and is a barrie...
Polycystic ovary syndrome: Panel recommends changing name of common disorder in women
An independent panel convened by the National Institutes of Health has concluded that the name of a common hormone disorder in women, polycystic ovary syndrome (PCOS), causes confusion and is a barrie...
Panel recommends changing name of polycystic ovary syndrome disorder in women
An independent panel convened by the National Institutes of Health has concluded that the name of a common hormone disorder in women, polycystic ovary syndrome (PCOS), causes confusion and is a barrie...
NIH Panel: Name Change, New Priorities Advised for Polycystic Ovary Syndrome
An estimated 5 million women in the United States live with a clinical paradox: they have a common hormone disorder called polycystic ovary syndrome, but many don't have ovarian cysts. The obvious dis...
Best Approaches to Polycystic Ovarian Syndrome
Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age.1 It is characterized by menstrual and ovulatory abnormalities, excess androgens and often...
Matching PubMed Articles
OBJECTIVE. To compare the effects of laparoscopic ovarian drilling in treating infertile polycystic ovarian syndrome in patients with and without metabolic syndrome. DESIGN. Retrospective review. SETT...
Unspecific Increase of Tumor Markers in a Girl with Nephrotic Syndrome and Ovarian Teratoma.
Coexistence of nephrotic syndrome and neoplasm is rarely observed in children. We report the diagnostic and therapeutic problems of a 16-year-old female with nephrotic syndrome, ovarian tumor, and inc...
The macrophage secretions' effect on ovarian steroidogenesis is investigated in a polycystic ovary syndrome rat model (PCO rat). The influence of testosterone environment on the expression of macropha...
Chronic low-grade inflammation has emerged as a key contributor to the pathogenesis of Polycystic Ovary Syndrome (PCOS). A dietary trigger such as glucose is capable of inciting oxidative stress and a...
Management of Polycystic Ovary Syndrome in Childhood and Adolescence.
Introduction: Polycystic ovary syndrome (PCOS) is a common endocrinopathy in women. It may manifest as early as in the first decade of life. Most often it becomes clinically apparent during adolescenc...
